IMTXSMALL

Immatics N.V.

HealthcareBiotechnology
$9.52
$0.00(-0.05%)
52W$5.05
$12.41
Updated Jun 29, 02:00 AM
RSI43
RS Rating33/99
Beta1.52
Volatility63%
F-Score2/9
Mkt Cap$1.3B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Immatics N.V. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings contraction of 30% provides fundamental context to the price action. Investors should exercise caution due to high volatility (63% annualized), which requires wider risk management.

Relative Strength
33
out of 99
Lagging
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.52
vs S&P 500
HIGH BETA
52W Position
61%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$10.61
50 SMA > 100 SMA$10.29
100 SMA > 150 SMA$10.21
150 SMA > 200 SMA$9.90

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$9.76-2.42%BELOW
50 SMA$10.61-10.26%BELOW
100 SMA$10.29-7.48%BELOW
150 SMA$10.21-6.77%BELOW
200 SMA$9.90-3.86%BELOW

Price Performance

1D-0.1%
1W-2.7%
1M-14.9%
3M-2.6%
6M-6.8%
YTD-8.9%
1Y+70.3%
3Y-5.3%
52-Week Trading Range61% from low
$9.52
52W Low$5.05
52W High$12.41

Technical Indicators

RSI (14)NEUTRAL
42.8
305070
Setup ScoreCOOL
5/10
Base depth: 33.4%

Risk Profile

Beta
1.52
52W Vol
63%
ATR
$0.50
Max DD (1Y)
-28%

Volume Analysis

Today
50D Avg
438.1K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-241%
$-0.58
Q3'25-282%
$-0.42
Q4'25-161%
$-0.28
Q1'26-30%
$-0.43
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+9.08%
3 Years:-34.64%
TTM:-74.13%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-10.40%

Stock Price CAGR

10 Years:-0.08%
5 Years:-4.30%
3 Years:-5.27%
1 Year:+70.30%

Return on Equity

10Y Avg:-152.9%
5Y Avg:-38.8%
3Y Avg:-25.9%
Last Year:-45.5%

Key Metrics

Market Cap$1.3B
Gross Margin1.0%
Net Margin-4.1%
Piotroski F-Score2/9

Frequently Asked Questions

Is IMTX in an uptrend right now?

IMTX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is IMTX overbought or oversold?

IMTX's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.

Is IMTX outperforming the market?

IMTX has a Relative Strength (RS) Rating of 33 out of 99. IMTX is currently lagging the broader market.

Where is IMTX in its 52-week range?

IMTX is trading at $9.52, which is 77% of its 52-week high ($12.41) and 61% above its 52-week low ($5.05).

How volatile is IMTX?

IMTX has a Beta of 1.52 and 52-week volatility of 63%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.